For: | Yeo CM, Chong VH, Earnest A, Yang WL. Prevalence and risk factors of methotrexate hepatoxicity in Asian patients with psoriasis. World J Hepatol 2013; 5(5): 275-280 [PMID: 23717738 DOI: 10.4254/wjh.v5.i5.275] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v5/i5/275.htm |
Number | Citing Articles |
1 |
Filiz Kazak, Ahmet Uyar, Pinar Coskun, Turan Yaman. Nobiletin alleviates methotrexate-induced hepatorenal toxicity in rats. Biotechnic & Histochemistry 2024; 99(3): 134 doi: 10.1080/10520295.2024.2335168
|
2 |
Tae Yeob Kim, Ji Yeoun Kim, Joo Hyun Sohn, Hye-Soon Lee, So-Young Bang, Yongsoo Kim, Min Yeong Kim, Woo Kyoung Jeong. Assessment of Substantial Liver Fibrosis by Real‐time Shear Wave Elastography in Methotrexate‐Treated Patients With Rheumatoid Arthritis. Journal of Ultrasound in Medicine 2015; 34(9): 1621 doi: 10.7863/ultra.15.14.10035
|
3 |
Rinki Verma, Varsha Rani, Manoj Kumar. In-vivo anticancer efficacy of self-targeted methotrexate-loaded polymeric nanoparticles in solid tumor-bearing rat. International Immunopharmacology 2023; 119: 110147 doi: 10.1016/j.intimp.2023.110147
|
4 |
Luciana Agoglia, Ana Carolina Cardoso, Lívia Barbosa, Cecília Schubert Xavier Lagalhard Victer, Sueli Carneiro, Paulo Henrique Condeixa de França, Maria Chiara Chindamo, Cristiane Alves Villela-Nogueira. Psoriasis and steatotic liver disease: Are PNPLA3 and TM6SF2 polymorphisms suitable for the hepato-dermal axis hypothesis?. Annals of Hepatology 2024; 29(4): 101477 doi: 10.1016/j.aohep.2024.101477
|
5 |
|
6 |
Mozhdeh Roghani, Heibatullah Kalantari, Mohammad Javad Khodayar, Layasadat Khorsandi, Mojtaba Kalantar, Mehdi Goudarzi, Hadi Kalantar. <p>Alleviation of Liver Dysfunction, Oxidative Stress and Inflammation Underlies the Protective Effect of Ferulic Acid in Methotrexate-Induced Hepatotoxicity</p>. Drug Design, Development and Therapy 2020; : 1933 doi: 10.2147/DDDT.S237107
|
7 |
Leila Jafaripour, Reza Naserzadeh, Ehsan Alizamani, SeyyedMohammad Javad Mashhadi, EbrahimRahmani Moghadam, Negar Nouryazdan, Hassan Ahmadvand. Effects of rosmarinic acid on methotrexate-induced nephrotoxicity and hepatotoxicity in wistar rats. Indian Journal of Nephrology 2021; 31(3): 218 doi: 10.4103/ijn.IJN_14_20
|
8 |
Hira Imad Cheema, Dirk Haselow, Jonathan Ankin Dranoff. Review of existing evidence demonstrates that methotrexate does not cause liver fibrosis. Journal of Investigative Medicine 2022; 70(7): 1452 doi: 10.1136/jim-2021-002206
|
9 |
Pasinee Rongngern, Leena Chularojanamontri, Chanisada Wongpraparut, Narumol Silpa-Archa, Watcharasak Chotiyaputta, Ananya Pongpaibul, Phunchai Charatcharoenwitthaya. Diagnostic performance of transient elastography for detection of methotrexate-induced liver injury using Roenigk classification in Asian patients with psoriasis: a retrospective study. Archives of Dermatological Research 2017; 309(5): 403 doi: 10.1007/s00403-017-1733-4
|
10 |
Qiaozhi Hu, Hualing Wang, Ting Xu. Predicting Hepatotoxicity Associated with Low-Dose Methotrexate Using Machine Learning. Journal of Clinical Medicine 2023; 12(4): 1599 doi: 10.3390/jcm12041599
|
11 |
Bridget P. Kaufman, Andrew F. Alexis. Psoriasis in Skin of Color: Insights into the Epidemiology, Clinical Presentation, Genetics, Quality-of-Life Impact, and Treatment of Psoriasis in Non-White Racial/Ethnic Groups. American Journal of Clinical Dermatology 2018; 19(3): 405 doi: 10.1007/s40257-017-0332-7
|
12 |
Devaraj Ezhilarasan. Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms. Toxicology 2021; 458: 152840 doi: 10.1016/j.tox.2021.152840
|
13 |
Tyng-Shiuan Hsieh, Tsen-Fang Tsai. Combination Therapy for Psoriasis with Methotrexate and Other Oral Disease-Modifying Antirheumatic Drugs: A Systematic Review. Dermatology and Therapy 2023; 13(4): 891 doi: 10.1007/s13555-023-00903-5
|
14 |
Ali Azzam, Zainab Jiyad, James O’Beirne. Is methotrexate hepatotoxicity associated with cumulative dose? A systematic review and meta‐analysis. Australasian Journal of Dermatology 2021; 62(2): 130 doi: 10.1111/ajd.13546
|
15 |
Maroua Slouma, Wided Lahmar, Ghanem Mohamed, Omar Dhrif, Rim Dhahri, Hedia Bellali, Imen Gharsallah, Nabil Ebdelli. Associated factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate. Clinical Rheumatology 2024; 43(3): 929 doi: 10.1007/s10067-023-06847-7
|
16 |
Amany M. Gad, Wedad A. Hassan, Ebtehal Mohammad Fikry. Significant curative functions of the mesenchymal stem cells on methotrexate‐induced kidney and liver injuries in rats. Journal of Biochemical and Molecular Toxicology 2017; 31(8) doi: 10.1002/jbt.21919
|
17 |
Azza A. K. El-Sheikh, Mohamed A. Morsy, Ahlam M. Abdalla, Azza H. Hamouda, Ibrahim A. Alhaider, Giuseppe Valacchi. Mechanisms of Thymoquinone Hepatorenal Protection in Methotrexate‐Induced Toxicity in Rats. Mediators of Inflammation 2015; 2015(1) doi: 10.1155/2015/859383
|
18 |
Tamilselvi Elango, Anburaj Jeyaraj, Haripriya Dayalan, Pushpa Gnanaraj, Xinghui Li, Xuejun Zhang. Psoriasis - New Research. 2022; doi: 10.5772/intechopen.102811
|
19 |
Zhi-cheng Zhang, Shui-juan Zhang, Bo Jin, Yujin Wu, Xin-fu Yang, Bing Yu, Qiang-min Xie. Ciclamilast Ameliorates Adjuvant-Induced Arthritis in a Rat Model. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/786104
|
20 |
David E. Kleiner. Drug-induced Liver Injury. Gastroenterology Clinics of North America 2017; 46(2): 273 doi: 10.1016/j.gtc.2017.01.004
|
21 |
Marco Fiore, Sebastiano Leone, Alberto Enrico Maraolo, Emilio Berti, Giovanni Damiani. Liver Illness and Psoriatic Patients. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/3140983
|
22 |
Ratchaya Lertnawapan, Soonthorn Chonprasertsuk, Sith Siramolpiwat. Association between cumulative methotrexate dose, non‐invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate. International Journal of Rheumatic Diseases 2019; 22(2): 214 doi: 10.1111/1756-185X.13442
|
23 |
Rachel P.L. van Swelm, Coby M.M. Laarakkers, Marisol Kooijmans-Otero, Elke M.G.J. de Jong, Rosalinde Masereeuw, Frans G.M. Russel. Biomarkers for methotrexate-induced liver injury: Urinary protein profiling of psoriasis patients. Toxicology Letters 2013; 221(3): 219 doi: 10.1016/j.toxlet.2013.06.234
|
24 |
AA Dar, A Fehaid, S Alkhatani, S Alarifi, WS Alqahtani, G Albasher, R Almeer, S Alfarraj, AE Abdel Moneim. The protective role of luteolin against the methotrexate-induced hepato-renal toxicity via its antioxidative, anti-inflammatory, and anti-apoptotic effects in rats. Human & Experimental Toxicology 2021; 40(7): 1194 doi: 10.1177/0960327121991905
|